Literature DB >> 7476312

Nutritional regulation of insulin-like growth factor-I.

J M Ketelslegers1, D Maiter, M Maes, L E Underwood, J P Thissen.   

Abstract

Several lines of evidence indicate that in the human, insulin-like growth factor-I (IGF-I) is nutritionally regulated. Both energy and protein availability are required for maintenance of IGF-I. Measurements of serum IGF-I constitute a sensitive means for monitoring the response of acutely ill patients to nutritional intervention. Serum IGF-I may also serve as a marker for evaluation of nutritional status. Our findings and those of others in animal models suggest that nutrients influence synthesis and action of IGF-I and its binding proteins (IGFBPs) at multiple levels. In fasting, liver growth hormone (GH) binding is decreased, providing one explanation for decreased IGF-I. In protein restriction, GH receptors are maintained, but there is evidence for a postreceptor defects. The latter results from pretranslational and translational defects. Amino acid availability to the hepatocytes is essential for IGF-I gene expression. Protein malnutrition not only decreases IGF-I production rate, but also enhances its serum clearance and degradation. Finally, there is evidence for selective organ resistance to the growth-promoting effects of IGF-I in protein-restricted rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476312     DOI: 10.1016/0026-0495(95)90221-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  26 in total

1.  Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.

Authors:  Monica McGrath; I-Min Lee; Julie Buring; Immaculata De Vivo
Journal:  Gynecol Oncol       Date:  2011-02       Impact factor: 5.482

2.  Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice.

Authors:  Karlton R Larson; Aki T-B Chaffin; Michael L Goodson; Yanbin Fang; Karen K Ryan
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 3.  Fasting and Caloric Restriction in Cancer Prevention and Treatment.

Authors:  Sebastian Brandhorst; Valter D Longo
Journal:  Recent Results Cancer Res       Date:  2016

4.  Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.

Authors:  M Brink; J Wellen; P Delafontaine
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

5.  Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy.

Authors:  Lisa M Freeman; John E Rush; Kathryn M Meurs; Barret J Bulmer; Suzanne M Cunningham
Journal:  J Feline Med Surg       Date:  2012-09-21       Impact factor: 2.015

6.  Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; J Bellone; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

Review 7.  Advantages and disadvantages of GH/IGF-I combination treatment.

Authors:  J A M J L Janssen
Journal:  Rev Endocr Metab Disord       Date:  2008-07-06       Impact factor: 6.514

8.  Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.

Authors:  Edoardo Parrella; Tom Maxim; Francesca Maialetti; Lu Zhang; Junxiang Wan; Min Wei; Pinchas Cohen; Luigi Fontana; Valter D Longo
Journal:  Aging Cell       Date:  2013-03-11       Impact factor: 9.304

9.  Bone deficits in parenteral nutrition-dependent infants and children with intestinal failure are attenuated when accounting for slower growth.

Authors:  Stephanie S Appleman; Heidi J Kalkwarf; Alok Dwivedi; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

10.  Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution.

Authors:  Marianna Beghini; Stephanie Brandt; Ingrid Körber; Katja Kohlsdorf; Heike Vollbach; Belinda Lennerz; Christian Denzer; Shlomit Shalitin; Ferruccio Santini; Werner F Blum; Julia von Schnurbein; Martin Wabitsch
Journal:  Int J Obes (Lond)       Date:  2021-05-17       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.